EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin
Cambier, Samantha, Sylvester, Richard J., Collette, Laurence, Gontero, Paolo, Brausi, Maurizio A., van Andel, George, Kirkels, Wim J., Silva, Fernando Calais Da, Oosterlinck, Willem, Prescott, StephenLanguage:
english
Journal:
European Urology
DOI:
10.1016/j.eururo.2015.06.045
Date:
July, 2015
File:
PDF, 1.12 MB
english, 2015
File converter
More search results
More benefits 
